Indonesian Antitrust Regulator Fines Pfizer Units $14M
By Abigail Rubenstein ( September 28, 2010, 2:18 PM EDT) -- Indonesia's antitrust agency KPPU has fined Pfizer Inc. and four subsidiaries a total of about $14 million for violating the country's anti-monopoly statutes by abusing its dominant position in the market for anti-hypertensive drugs to overcharge consumers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.